Mosla scabra
Mosla scabra · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Mosla scabra is a botanical species recognized for its diverse therapeutic potential in traditional medicine. The plant contains significant bioactive compounds, most notably the chemical Magnosalin, which is found within its structure. Researchers have focused heavily on the medicinal properties of its leaves, exploring various preparations such as total flavonoids from M. scabra (MSTF) and total lignans (MSTL). These extracts are being studied for their efficacy in addressing respiratory conditions, including chronic obstructive pulmonary disease and persistent coughs. Furthermore, the whole plant is investigated for its ability to combat serious ailments like viral infection and viral pneumonia.
- Synonyms
- Mosla Punctulata · Orthodon Scaber · 5 more
- Common names
- Not available
- Family
- Lamiaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Common Names
Mosla scabra is a versatile plant known by a wide variety of regional and descriptive names. In many English-speaking circles, it is affectionately referred to as Mini-shiso or simply as Mosla. The plant also holds significant linguistic importance in East Asia, where it is identified as イヌコウジュ. This botanical identity is further reflected in its traditional Chinese designations, such as 犬香薷. Additionally, it can be found documented under the specific name 石薺薴 in certain botanical contexts.
Sources: Catalogue of Life (COL)
Synonyms
Mosla scabra is a botanical species characterized by a complex history of taxonomic nomenclature. Throughout various scientific classifications, this plant has been identified by several different synonyms, including Mosla lanceolata and Mosla punctulata. It is also frequently linked to the name Ocimum punctulatum in older botanical records. Further historical literature often refers to the specimen as Ocimum scabrum. Additionally, the name Orthodon lanceolatus serves as another recognized synonym within its shifting scientific identity.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Mosla scabra is a distinctive organism belonging to the kingdom Plantae. Within this vast biological group, it is specifically classified under the class Equisetopsida. The plant further belongs to the order Lamiales, showcasing its evolutionary connections. Its lineage continues through the family Lamiaceae, a group known for its diverse botanical characteristics. Ultimately, this species is identified by its unique placement within the genus Mosla.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Lamiales |
| Family | Lamiaceae |
| Genus | Mosla |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Mosla scabra is a plant species primarily found throughout the Asia-Temperate region. Within this broad range, it maintains a significant presence across various parts of China, including the North-Central and South-Central territories. Its distribution also extends into the Southeast region of the country, showcasing its adaptability to different climates. Furthermore, the species can be identified in the northern reaches of Inner Mongolia. Finally, its natural habitat encompasses the Manchuria area, rounding out its widespread geographical footprint.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Mosla scabra is a self-supporting herb characterized by its compact and sturdy growth form. This plant typically reaches a modest maximum height of only 0.6 meters. Such physical attributes make it a subtle yet distinct presence within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Mosla scabra is a natural medicinal plant recognized for its diverse chemical profile and therapeutic potential. Research indicates that the plant contains several key bioactive flavonoids, including kaempherol, luteoloside, apigenin, and luteolin. In addition to these flavonoids, the plant is also a source of the known lignan magnosalin. These various compounds contribute to the plant's ability to interact with specific biological targets within the body. Together, these constituents highlight the complex phytochemical makeup that drives the medicinal properties of Mosla scabra.
Conditions
Mosla scabra is a natural medicinal plant utilized for treating various lung and gastrointestinal diseases. It is specifically known to treat viral infections and help manage conditions such as cough and chronic obstructive pulmonary disease. Additionally, the plant serves as a therapeutic agent for gastrointestinal issues, including acute gastroenteritis and diarrhoea. These diverse medicinal properties highlight its importance in addressing both respiratory and digestive ailments.
Preparations
Mosla scabra serves as the source for various medicinal preparations, including total flavonoids (MSTF), total lignans (MSTL), and the whole plant itself. The total flavonoids extracted from M. scabra are utilized to combat influenza A virus-induced pneumonia by inhibiting specific inflammatory pathways. Similarly, the total lignans derived from the plant have been shown to protect macrophages and ameliorate lung injury during viral infections. Furthermore, specific cyclobutane-type lignans are isolated directly from the whole plant of Mosla scabra. These different preparations highlight the plant's diverse chemical profile and its therapeutic potential in treating respiratory conditions.
Parts used
Mosla scabra leaves have been identified as a significant natural product in studies investigating lung health. Research indicates that these leaves can play a role in mitigating the damage caused by various noxious agents. Specifically, they contribute to the amelioration of lung injury by influencing inflammatory cells and oxidative stress markers. This medicinal property suggests that the plant may offer therapeutic benefits for respiratory disorders. However, additional clinical studies are required to fully validate these effects for practical medical use.